Mankind Pharma (MANKIND) — Board Meeting

📢 Key Event
Independent Director Bharat Anand completes second term and exits all board committees

🔄 What Changed
Completion of second term as Independent Director and removal from Audit, Nomination, Risk Management, and CSR Committees

💡 Investor Takeaway
This leadership change may affect governance continuity and committee oversight for shareholders to monitor.

Mankind Pharma announced that Independent Director Bharat Anand completed his second term effective August 30, 2026, and ceased membership from all four board committees including Audit and Risk Management, with the board expressing appreciation for his contributions.

📄 View Original Announcement (PDF)

📊 Stock Analysis — MANKIND ✨ Ask AI About This

About Mankind Pharma Ltd (MANKIND)

Healthcare · Pharmaceuticals · Listed on BSE

Market Cap: ₹97,467.05 Cr P/E: 47.7 ROE: 12.7% ROCE: 13.9% Div Yield: 0.04%

View full MANKIND stock details →

📡 Get AI alerts when MANKIND files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track MANKIND — Free

💡 Ask AI about this filing

"How will the board composition impact future governance decisions?" "What is the process for appointing his replacement?" "Will committee oversight changes affect financial reporting timelines?"

Ask AI Free →

📊 More MANKIND filings

See all MANKIND filings →

🔥 Also filed on 30 August 2026

OIL Oil India Ltd Announcement TIPSMUSIC Tips Music Ltd Announcement VOEPL Virtuoso Optoelectronics Ltd Announcement 531233 Rasi Electrodes Ltd Annual Report 539449 IGC Industries Ltd Annual Report LINC Linc Ltd Announcement

View all today's announcements →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when MANKIND files new disclosures

Track MANKIND filings, board meetings, and corporate actions. Free email alerts at 5 PM.

Track MANKIND — Free

Free account · 2 AI queries/day

About · Privacy Policy · Terms of Service · Pricing

Today's Announcements · Screener · Insights · AI Chat

Data provided by CMOTS Internet Technologies Pvt Ltd